Italy· 033232012

GADRAL

A magaldrate product containing magaldrato, registered in Italy by NEOPHARMED GENTILI S.P.A., on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC A02AD02

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedGADRALATCA02AD02REGISTER NO.033232012PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Magaldrate is registered in 6 of 19 countries.

Countries holding a registration under ATC A02AD02 (magaldrate), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 4 of them publish a price we can compare per daily dose

Magaldrate · ATC A02AD02

6 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Germany
  • Italyprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of magaldrate costs, country by country.

Normalised to the WHO defined daily dose (3.2 g), the median price runs from $0.54 in Italy to $1.43 in Switzerland — a ×2.6 gap.

  • Italy: $0.54 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Magaldrate · price per daily dose (3.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.43
  • IT Italy$0.54
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Magaldrato
Manufacturer
NEOPHARMED GENTILI S.P.A.
Country
Italy (IT)
ATC code
A02AD02
ATC class
Magaldrate
Defined daily dose
3.2 g, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    033232012
    "800 MG COMPRESSE MASTICABILI"40 COMPRESSE
    EUR 4.78

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

223 interactions on record for magaldrate.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Magaldrate · interactions on record

223 records

  • 8 severe
  • 106 moderate
  • 93 minor

Most severe, free to view

  • RaltegravirJ05AJ01severe
  • DolutegravirJ05AJ03severe
  • RaltegravirJ05AX08severe
  • DolutegravirJ05AX12severe

16 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Magaldrate in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All magaldrate products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Austria · Riopan
  • Belgium · Riopan
  • Germany · Magaldrat Ratiopharm, Riopan Btl
  • Spain · Bemolan, Magión
  • Greece · Riopan
  • Luxembourg · Riopan
  • Portugal · Riopan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/55c04c62-8d3a-4fb8-9348-efe4d159f51c
GET /v1/drugs/55c04c62-8d3a-4fb8-9348-efe4d159f51c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"800 MG COMPRESSE MASTICABILI\"40 COMPRESSE",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Magaldrato",
  "reference_pack": "40 UNITA' 800 MG - USO ORALE",
  "public_price_eur": 4.78,
  "ssn_reference_price_eur": 4.78
}

See everything about magaldrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.